82 related articles for article (PubMed ID: 11816739)
1. [Bone complication in diabetes subjects with good metabolic control and without longterm complications: certain problems. Part II. Basal parameters of bone turnover].
Zywiec J; Grzeszczak W; Pierzchała K
Przegl Lek; 2001; 58(6):495-7. PubMed ID: 11816739
[TBL] [Abstract][Full Text] [Related]
2. [Bone complications in diabetic subjects with good metabolic control and without any long-term complications--certain problems. Part III: The influence of hypertension and type 2 diabetes mellitus co-incidence of calcium, phosphorus and magnesium metabolism].
Zywiec J; Grzeszczak W; Pierzchała K
Przegl Lek; 2001; 58(7-8):778-81. PubMed ID: 11769386
[TBL] [Abstract][Full Text] [Related]
3. [Bone complication in diabetic subjects with good metabolic control and without any late complications: selected problems. Part I: calcium, phosphorus and magnesium metabolism].
Zywiec J; Grzeszczak W; Pierzchała K
Przegl Lek; 2001; 58(5):426-30. PubMed ID: 11603176
[TBL] [Abstract][Full Text] [Related]
4. Bone calcium changes during diabetic ketoacidosis: a comparison with lactic acidosis due to volume depletion.
Topaloglu AK; Yildizdas D; Yilmaz HL; Mungan NO; Yuksel B; Ozer G
Bone; 2005 Jul; 37(1):122-7. PubMed ID: 15869925
[TBL] [Abstract][Full Text] [Related]
5. Bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in thyrotoxicosis.
Broulik PD; Stĕpán JJ; Límanová Z; Pacovský V
Endocrinol Exp; 1985 Sep; 19(3):165-9. PubMed ID: 3876205
[TBL] [Abstract][Full Text] [Related]
6. Urine products of bone breakdown as markers of bone resorption and clinical usefulness of urinary hydroxyproline: an overview.
Simsek B; Karacaer O; Karaca I
Chin Med J (Engl); 2004 Feb; 117(2):291-5. PubMed ID: 14975218
[TBL] [Abstract][Full Text] [Related]
7. [Selected indicators of calcium-phosphate metabolism in patients with diabetes mellitus].
Błasiak M; Kuska J; Kokot F; Irzyniec T
Endokrynol Pol; 1989; 40(5):251-62. PubMed ID: 2641514
[TBL] [Abstract][Full Text] [Related]
8. [Assessment of bone resorption/neoformation indexes in obese women before and after weight loss].
Sartorio A; Conti A; Grugni G; De Medici C; Morabito F; Ambrosi B; Faglia G
Minerva Endocrinol; 1990; 15(2):117-20. PubMed ID: 2098652
[TBL] [Abstract][Full Text] [Related]
9. [Psoriatic osteopathy].
Hein G; Abendroth K; Müller A; Wessel G
Z Gesamte Inn Med; 1989 Nov; 44(22):674-7. PubMed ID: 2626847
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of copper supplementation on deposition of fluoride in bone in fluoride- and molybdenum-fed rabbits.
Khandare AL; Suresh P; Kumar PU; Lakshmaiah N; Manjula N; Rao GS
Calcif Tissue Int; 2005 Oct; 77(4):233-8. PubMed ID: 16193231
[TBL] [Abstract][Full Text] [Related]
11. [Osteopathy in diabetic foot syndrome].
Dedov II; Iushkov PV; Tokmakova AIu; Ul'ianova IN
Arkh Patol; 2004; 66(1):10-4. PubMed ID: 15055102
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements.
Akin O; Göl K; Aktürk M; Erkaya S
Gynecol Endocrinol; 2003 Feb; 17(1):19-29. PubMed ID: 12724015
[TBL] [Abstract][Full Text] [Related]
13. Increasing serum osteocalcin after glycemic control in diabetic men.
Sayinalp S; Gedik O; Koray Z
Calcif Tissue Int; 1995 Dec; 57(6):422-5. PubMed ID: 8581873
[TBL] [Abstract][Full Text] [Related]
14. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
[TBL] [Abstract][Full Text] [Related]
15. Experimental hyperhomocysteinemia disturbs bone metabolism in rats.
Ozdem S; Samanci S; Tasatargil A; Yildiz A; Sadan G; Donmez L; Herrmann M
Scand J Clin Lab Invest; 2007; 67(7):748-56. PubMed ID: 17852810
[TBL] [Abstract][Full Text] [Related]
16. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
[TBL] [Abstract][Full Text] [Related]
17. Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats.
Elwakkad AS; El Elshamy KA; Sibaii H
Epilepsy Res; 2008 Jul; 80(1):47-56. PubMed ID: 18455911
[TBL] [Abstract][Full Text] [Related]
18. Body iron stores in relation to the metabolic syndrome, glycemic control and complications in female patients with type 2 diabetes.
Mojiminiyi OA; Marouf R; Abdella NA
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):559-66. PubMed ID: 18063352
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes.
Hamilton EJ; Rakic V; Davis WA; Chubb SA; Kamber N; Prince RL; Davis TM
Diabet Med; 2009 Jan; 26(1):45-52. PubMed ID: 19125760
[TBL] [Abstract][Full Text] [Related]
20. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
